NVST
NYSE
US
Envista Holdings Corporation Common Stock
$27.73
▲ +$0.79
(+2.93%)
Vol 54K
Mkt Cap
$4.4B
P/E
93.9
ROE
1.5%
Margin
1.7%
Beta
0.98
52W
$15–$30
Wall Street Consensus
20 analysts · Apr 20267
Strong Buy
5
Buy
8
Hold
0
Sell
0
Strong Sell
60.0%
Buy Rating
Price Chart
Similar Stocks
MASI
Masimo Corp
$7.0B
BAX
Baxter International Inc
$9.3B
GKOS
Glaukos Corp
$7.1B
TFX
Teleflex Inc
$5.7B
IRTC
iRhythm Holdings, Inc
$5.7B
TMDX
Transmedics Group Inc
P/E 45.3
$4.2B
ITGR
Integer Holdings Corp
P/E 29.6
$3.0B
LMAT
LeMaitre Vascular Inc
P/E 34.5
$1.8B
AORT
Artivion Inc
P/E 183.1
$1.8B
ABT
Abbott Laboratories
P/E 26.3
$165.2B
Earnings
Beat rate: 100.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $0.33 | $0.38 | +$0.05 |
| Sep 2025 | $0.28 | $0.32 | +$0.04 |
| Jun 2025 | $0.24 | $0.26 | +$0.02 |
| Mar 2025 | $0.21 | $0.24 | +$0.03 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | $652.9M | $616.9M | $682.1M | $669.9M | $750.6M |
| Net Income | — | $1.2M | $18.0M | $26.4M | -$30.3M | $32.9M |
Fundamentals Trend
| Metric | 2026-04-12 | 2026-04-17 |
|---|---|---|
| ROE (TTM) | 1.5% | 1.5% |
| P/E (TTM) | 92.01 | 93.93 |
| Net Margin | 1.7% | 1.7% |
| Gross Margin | 55.0% | 55.0% |
| D/E Ratio | — | — |
| Current Ratio | 2.38 | 2.38 |
Key Ratios
ROA (TTM)
0.8%
P/S (TTM)
1.62
P/B
1.1
EPS (TTM)
$0.28
CF/Share
$1.87
Rev Growth 3Y
+1.9%
52W High
$30.42
52W Low
$14.72
$14.72
52-Week Range
$30.42
Financial Health
Free Cash Flow
$91.7M
Net Debt
$386.0M
Cash
$1.2B
Total Debt
$1.6B
As of Dec 31, 2025
How does NVST compare to Health Care peers?
Peer group: Peers · Health Care (Peers) · 10 companies
NVST valuation vs Health Care peers
P/E ratio
92.0
▲
167%
above
peers
(34.5)
vs Peers
vs Industry
Pricier
P/S ratio
1.6
▼
60%
below
peers
(4.0)
vs Peers
vs Industry
Undervalued
P/B ratio
1.2
▼
78%
below
peers
(5.2)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(1.1%)
vs Peers
vs Industry
In line
NVST profitability vs Health Care peers
ROE
1.5%
▲
125%
above
peers
(-6.1%)
vs Peers
vs Industry
Below avg
Net margin
1.7%
▲
162%
above
peers
(-2.8%)
vs Peers
vs Industry
Below avg
Gross margin
55.0%
▼
1%
below
peers
(55.9%)
vs Peers
vs Industry
In line
ROA
0.8%
▲
145%
above
peers
(-1.9%)
vs Peers
vs Industry
Below avg
NVST financial health vs Health Care peers
D/E ratio
—
▼
0%
below
peers
(106.5)
vs Peers
vs Industry
In line
Current ratio
2.4
▼
23%
below
peers
(3.1)
vs Peers
vs Industry
Low liquidity
Beta
1.0
▲
24%
above
peers
(0.8)
vs Peers
vs Industry
More volatile
NVST fundamentals radar
NVST
Peer median
Industry
NVST profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
NVST vs peers: key metrics
Insider Activity
BearishBuys
8
Sells
1
$290250
HAMMES ERIC D.
Chief Financial Officer · Feb 25
award
16055 shs
KEEL PAUL A
Chief Executive Officer · Feb 25
award
48670 shs
NANCE MARK E
General Counsel · Feb 25
award
12675 shs
REIS MISCHA
Officer · Feb 25
award
5915 shs
KAABI FAEZ C
Officer · Feb 25
award
13520 shs
BEFIDI ROBERT JR.
Officer · Feb 25
award
7605 shs
ACURIO VERONICA
Officer · Feb 25
award
7605 shs
NILSSON STEFAN
Officer · Feb 25
award
7605 shs
REIS MISCHA
Officer · Feb 10
sale
9675 shs
REIS MISCHA
Officer · Feb 10
conversion of exercise of derivative security
9675 shs
Last 90 days
Top Holders
Top 5: 39.3%Blackrock Inc.
10.76%
$462.9M
Vanguard Group Inc
9.88%
$424.8M
Ariel Investments, LLC
7.34%
$315.9M
Dimensional Fund Advisors LP
5.91%
$254.1M
Morgan Stanley
5.41%
$232.5M
As of Dec 31, 2025
Latest News
No related news yet